CARA ASCARRUNZ: Open Payments
NPI 1528641693 · DURANGO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 19 payments from 8 companies in 2025. Trend: 2023 $395 · 2024 $532 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $166 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| GENZYME CORPORATION | 2 | $59 |
| Amgen Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Lilly USA, LLC | 1 | $24 |
| Organon LLC | 1 | $2 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, OTEZLA, TREMFYA, COSENTYX, TALTZ.
Industry payments across CO — which companies pay providers there.
